News

| Danielle Skald
October 1st, 2017

Gornitzky represents the underwriters, led by Cowen and Company and Wells Fargo, in MediWound’s follow-on offering on NASDAQ.

Gornitzky represented the underwriters, led by Cowen and Company and Wells Fargo Securities, in the USD 25 million follow-on offering of MediWound Ltd. on the NASDAQ Global Market. MediWound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications.

 

Cowen and Company, LLC and Wells Fargo Securities, LLC acted as joint book-running managers for the offering. Oppenheimer & Co. Inc. and SunTrust Robinson Humphrey, Inc. acted as co-lead managers for the offering. Aegis Capital Corp. acted as a co-manager for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Sagit Amit Evan (Senior Associate), together with Associates Danielle Skald and Daniella Segal.

August 3rd, 2017

Gornitzky represents the underwriters, led by Cantor Fitzgerald, in Kamada's follow-on offering. 

Gornitzky represented the underwriters, led by Cantor Fitzgerald, in the USD 15 million follow-on offering of Kamada Ltd. on the NASDAQ Global Select Market. Kamada is a plasma-derived protein therapeutics company focused on orphan indications, and its shares are dually traded on the NASDAQ and the Tel Aviv Stock Exchange.

Cantor Fitzgerald acted as sole book-running manager for the offering. Raymond James, Oppenheimer & Co., Ladenburg Thalmann and Chardan acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Yoav Meer (Associate), Danielle Skald (Associate) and Sharon Strauss (Associate).

August 30th, 2016

Gornitzky represents SeaSpine in an agreement to acquire the assets of NTL Spine, an expandable interbody platform technologies company. In the acquisition, most of NTL Spine’s assets will be transferred to SeaSpine

Gornitzky together with DLA Piper represented SeaSpine in an agreement to acquire the assets of NTL Spine, an expandable interbody platform technologies company.

In the acquisition, most of NTL Spine’s assets will be transferred to SeaSpine. NLT Spine will receive an initial payment of USD 1 million and further payments in stock conditional upon meeting milestones, and altogether, stands to receive USD 5 million in milestone payments and up to USD 43 million in royalties. NTL Spine was founded by Dr. Tzony Siegal in 2006. It is a graduate of the Incentive incubator in Ariel, and among its later investors are Accelmed and Peregrine Ventures. NLT president and CEO Didier Toubia said that the company sees SeaSpine as the ideal partner to lead NTL’s innovative solutions in the market.

 

See full story in Globes

 

SeaSpine was represented by Chaim Friedland (partner). Yoni Raff, Avi Meer and Daniel Skald

April 11th, 2016

Gornitzky & Co. is representing AHAVA shareholders in connection with the sale of 100% of AHAVA's shares to Fosun Group for an aggregate price of NIS 290 million

Gornitzky represented the shareholders of AHAVA - Dead Sea Laboratories Ltd., a manufacturer of cosmetic products composed of mineral-rich mud from the Dead Sea. Its products are sold in over 25 different countries. Gornitzky advised the shareholders in connection with the sale of 100% of the shares to the large Chinese investment conglomerate, Fosun Group, for an aggregate price of NIS 290 million. Within the framework of the agreement, Fosun will purchase the share capital of all of AHAVA’s shareholders, Gaon Holdings, the Livnat family, Shamrock Israel Growth Fund, Kibbutz Mitzpeh Shalem and Kibbutz Kalia.

 

See related article in Globes, one of Israel’s leading financial daily newspapers.

 

The shareholders were represented by Chaim Friedland (Partner, Corporate/M&A), Yoav Meer  (Corporate), Nir Knoll (Corporate), Danielle Skald (Tax), Bar Sarafian (Employment)

August 31st, 2014

Gornitzky represented 3D Systems Inc. in the USD 120 million cash acquisition of Simbionix.

Gornitzky represented 3D Systems Inc. in the USD 120 million cash acquisition of Simbionix USA Corp., a developer of 3D virtual reality simulation systems for training doctors to conduct complex surgical and treatment procedures.

 

3D Systems Inc. (NYSE: DDD) was represented by Chaim Friedland (Partner), Daniel Paserman (Partner, Tax), Avi Meer and Danielle Skald.

August 28th, 2017

Gornitzky represents the underwriters, led by Oppenheimer & Co., in Intec Pharma’s offering.

Gornitzky represented the underwriters, led by Oppenheimer & Co., in the USD 57.5 million follow-on offering of Intec Pharma Ltd. on the NASDAQ Capital Market. Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology.

 

Oppenheimer & Co. Inc. acted as sole book-running manager for the offering. Roth Capital Partners acted as lead manager, and Maxim Group LLC acted as co-manager for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Danielle Skald (Associate) and Nir Knoll (Associate).

December 19th, 2016

Gornitzky represents Sabon Shel Pa’am and its Shareholders in the Sale by its shareholders of approximately 70% of the shareholding of Sabon to Yves Rocher Group

Gornitzky represented Sabon Shel Pa’am (“Sabon”) and its Shareholders in the sale by its shareholders of approximately 70% of the shareholding of Sabon to Yves Rocher Group. Sabon is a leading producer and retailer of cosmetic, body care, home style and ambience products sold in concept stores around the world. Yves Rocher is a worldwide cosmetics and beauty brand, based in La Gacilly, France. Yves Rocher is present in 88 countries on five continents

As part of the transaction, the selling shareholders will continue to hold a significant position in the global company and shall take an active role in the management of the company for the next several years, after which they shall have an exit right. In addition to negotiating the sale agreement, we were required to negotiate a shareholders agreement between Yves Rocher and the selling shareholders for the relationship between the parties and the management of the companies.

For further reading in the Marker (Hebrew)

Sabon Shel Pa’am (“Sabon”) and its Shareholders is represented by Chaim Friedland (partner), Yehonatan Raff, Yoav Meer, Sam Berkowitz, Danielle Skald (tax) and Bar Sarafian (labour)

August 17th, 2016

Gornitzky represents the American car manufacturing Ford in in a multi-million dollar acquisition of SAIPS, an Israeli computer vision and machine learning company. 

Gornitzky represented the American car manufacturing Ford in connection with the acquisition of SAIPS, an Israeli computer vision and machine learning company. Ford announced the acquisition as part of its pledge to develop a commercial fully autonomous vehicle fleet by 2021.

 

See full story in Globes

 

Ford was represented by Chaim Friedland (Partner) Daniel Paserman (Partner, Tax), Yehonatan Raff, Aviad Rabinowitz, Danielle Skald (Tax) and Bar Sarafian.

February 9th, 2015

Gornitzky represented 3D Systems Corporation (NYSE: DDD) in its USD 97 million acquisition of all outstanding shares in Cimatron Ltd. (NASDAQ: CIMT), a leading provider of integrated 3D CAD/CAM software products.

Gornitzky represented 3D Systems Corporation (NYSE: DDD) in its USD 97 million acquisition of all outstanding shares in Cimatron Ltd. (NASDAQ: CIMT), a leading provider of integrated 3D CAD/CAM software products.

 

3D Systems Corporation, a market leader in 3D printing, was represented by Chaim Friedland (Partner), Assaf Harel, Yehontan Raff, Danielle Skald (Tax), Bar Sarafian (Labor Law) and Ben Goldman.